Top Markets
Coin of the day
Caliway Biopharmaceuticals Co. L Caliway Biopharmaceuticals Co. L

Caliway Biopharmaceuticals Co. L

6919
Kedudukan dalam Saham #3556
Caliway Biopharmaceuticals Co., Ltd., and its affiliated entities, is dedicated... Caliway Biopharmaceuticals Co., Ltd., and its affiliated entities, is dedicated to developing pharmaceuticals primarily in the fields of aesthetic medicine and chronic inflammation. Its lead investigational drug, CBL-514, is currently undergoing Phase 2 clinical trials, targeting non-surgical fat reduction, Dercum's disease, and cellulite. Beyond this, the firm is also progressing CBA-539 through preclinical exploration for potential applications in central obesity, hyperpigmentation, and skin aging. The company's offerings also extend to dietary supplements. Established in 2012, Caliway Biopharmaceuticals operates from its headquarters in New Taipei City, Taiwan.
Harga Saham
$3.28
Disegerakkan terakhir: 2026-07-31
Modal Pasaran
$5.10B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-49.70%
Negara
TW
Perdagangan Caliway Biopharmaceuticals Co. L (6919)

Kategori

Sejarah harga saham bagi Caliway Biopharmaceuticals Co. L (6919)
Harga penutupan tertinggi: $3.30 pada 2026-07-01

Harga penutupan terendah: $0.20 pada 2022-12-01
Sejarah harga saham Caliway Biopharmaceuticals Co. L dari 2022 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) -13.85%
2025 190.26%
2024 181.33%
2023 210.73%
2022 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$122.12 -12.63%
AU
$772.27 7.33%
CH